Investors may not be putting enough stock in Solazyme's IP

12/4/2013 | Seeking Alpha

Despite a recent construction delay that drove down Solazyme's stock price, the company's intellectual property has long-term value that investors may be overlooking, Kevin Quon writes. Solazyme's new C8-C10 rich oil has benefits for lubricants, nutrition, personal care and oleochemicals, he notes. "In order to achieve the same yield, a customer must purchase more than four times the amount of coconut oil just to match the volume derived from Solazyme's oil."

View Full Article in:

Seeking Alpha

Published in Brief: